# Karyopharm Therapeutics Inc.: Form 8-K, filed Oct 22, 2026

- Company: [Karyopharm Therapeutics Inc.](/companies/kpti.md) (CIK 1503802)
- Form: 8-K
- Filed: 2026-10-22
- Accepted by EDGAR: Oct 22, 2026, 16:15 ET
- Period: 2026-10-22
- Accession: 0001193125-26-428938
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1503802/000119312526428938/d172630d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1503802/000119312526428938/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1503802/000119312526428938/d172630d8k.htm

Filed Oct 22, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-428938. Last ingested by Listed: Nov 14, 2026, 19:58 ET. No prices; not investment advice.
